0000000000115328

AUTHOR

Florian Hladik

showing 2 related works from this author

IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-p)

1993

Experimental animal and human in vivo studies have previously demonstrated the impact of exogenous administration of various cytokines on frequencies of circulating myeloid and LAK precursor cells. For the first time we investigated whether exogenous cytokines, in the absence of antigenic challenge, may also influence frequencies of circulating antigen-specific cytotoxic T-lymphocyte precursor cells. We further asked whether triggering of autoimmune pathways as has been reported for several cytokines can be confirmed on the cellular level by demonstration of induction of autoreactive CTL-p. Limiting dilution analysis was used to determine alloreactive CTL-p frequencies in 31 patients with n…

Interleukin 2Stem Cellsmedicine.medical_treatmentClone (cell biology)Autoimmunityhemic and immune systemschemical and pharmacologic phenomenaHematologyGeneral MedicineBiologyRecombinant ProteinsInterferon-gammaCTL*CytokineImmunologymedicineSystemic administrationHumansInterleukin-2Cytotoxic T cellInterleukin-3Interferon gammaT-Lymphocytes CytotoxicInterleukin 3medicine.drugAnnals of Hematology
researchProduct

Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor …

1995

Recombinant human colony stimulating factors (CSFs) as single agents are increasingly used for mobilizing peripheral blood progenitor cells (PBPCs) for stem cell transplantation. We have shown in rhesus monkeys that interleukin-3 (IL-3) pretreatment markedly potentiated the increase in PBPC numbers of subsequent administration of granulocyte/macrophage-CSF (GM-CSF). Here we studied the effect of IL-3 pretreatment on GM-CSF-induced mobilization of PB progenitors in patients who were potential candidates for autologous stem cell transplantation (n = 16). Patients were treated with GM-CSF at a dose of 5 micrograms/kg/d for 5 d and after a treatment free interval received another cycle of GM-CS…

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentGranulocyteLeukocyte CountInternal medicinemedicineHumansProgenitor cellInterleukin 3business.industryPlatelet CountGranulocyte-Macrophage Colony-Stimulating FactorHematologyColony-stimulating factorHematopoietic Stem CellsTransplantationCytokineEndocrinologymedicine.anatomical_structureGranulocyte macrophage colony-stimulating factorImmunologyErythrocyte CountFemaleInterleukin-3Stem cellbusinessmedicine.drugBritish journal of haematology
researchProduct